Skip to content

A Powerful Story- An Evaluation Study of a Life Story Intervention to promote Recovery in People with Personality Disorders in the Third-line Health Care

A Powerful Story- An Evaluation Study of a Life Story Intervention to promote Recovery in People with Personality Disorders in the Third-line Health Care - A Powerful Story

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON48083
Enrollment
14
Registered
2019-01-22
Start date
2019-02-27
Completion date
Unknown
Last updated
2024-04-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

emotional dysregulation personality problems

Interventions

None listed

Sponsors

Universiteit Twente
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: To qualify for participation in this research, a patient must: 1. Follow a treatment at Scelta, GGNet 2. Have been approved to participate by his responsible therapist 3. Be able to complete this intervention during the treatment at Scelta ;Explanation: Inclusion criterion 2: The main responsible therapist decides in consultation with the patient whether it is appropriate to participate in the module. The main responsible therapist makes use of the following screening criteria:   - There is no contraindication present, such as serious instability or being in an acute crisis (GAF score not lower than 50) or the presence of psychosis or acute suicidality. This criterion implies that a participant must be mentally competent to participate.   - A patient must be able to look at the past with some distance, as shown by at least one contribution during the treatment program in a psychotherapy session.    - A patient must be able to look forward to recovery, as demonstrated by at least one contribution during the treatment program in the social reintegration part ;There is no inclusion criterion for therapists. It concerns practitioners who work at Scelta.

Exclusion criteria

Exclusion criteria: The exclusion criteria for participation in this study are: - low IQ (lower than 80) - not able to participate in a group form - antisocial personality disorder - insufficient command of the Dutch language These criteria were already screened during admission for treatment at Scelta. For taking part in 'Een Sterk Verhaal' they will be checked again by the main responsible therapist, who assesses whether the module seems feasible and is suitable for the patient.;In addition to the standard exclusion criteria, additional exclusion criteria have been added for this study: - presence of contraindication (such as severe instability or being in an acute crisis (GAF score lower than 50) or the presence of psychosis or acute suicidality, implying no mental competence) ;There is no exclusion criterion for therapists. It concerns practitioners who work at Scelta.

Design outcomes

Primary

MeasureTime frame
The primary outcome measure is the feasibility of the intervention as reported by participants (patients and practitioners) and by an observer present at the sessions. This is done on the basis of the Client Satisfaction Questionnaire (CSQ, Larsen, Attkisson, Hargreaves, & Nguyen, 1979; Dutch translation: De Brey, 1983), which is administered to the practitioners after each session, the Helpful Aspects of Therapy form (HAT; Llewelyn et al., 1988; Eliott, 2012), which is administered to the patients after each session, the observations of adherence and treatment integ- rity at each session and the evaluation of the entire intervention afterwards (CSQ for both practitioners and patients).

Secondary

MeasureTime frame
A second outcome measure is the change in recovery based on the Mental Health Recovery Measure (MHRM, van Nieuwenhuizen et al., 2013, Young & Bullock, 2005). A third outcome measure is the therapy course based on shared stories during the sessions and a qualitative analysis of the end product.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)